USPTO trademark

CURE8

RegisteredUSPTOWord markClass 42

"CURE8" is a word mark owned by Progenics Pharmaceuticals, Inc., filed at the USPTO on January 24, 2023. It is registered and covers class 42 (Computer and Scientific Services).

View Progenics Pharmaceuticals, Inc. portfolioGet this data via the API
Official USPTO record
CURE8 trademark as filed
As filed with the USPTO
Status
Registered
Since January 16, 2024
Filed
January 24, 2023
Registered
January 16, 2024
Expires
Not recorded
Application no.
97766262
Registration no.
7279000
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
1 class
Ownership

Who owns CURE8

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Progenics Pharmaceuticals, Inc.

North Billerica, United States

61 trademarks in the portfolioView company

Representative

Douglas R. Wolf

Wolf, Greenfield & Sacks, P.C.

Goods and services

What the mark covers

The products and services CURE8 is filed for, grouped by Nice class.

  • Providing temporary use of online, non-downloadable software for the storage of patient medical data and medical imaging data, the diagnosis and treatment of cancer, and medical data analysis; platform as a service (PAAS) featuring computer software platforms for the storage of patient medical data and medical imaging data, the diagnosis and treatment of cancer, and medical data analysis

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Notice of registration confirmation emailed
  2. Notice of registration confirmation emailed
  3. Registered-principal register
  4. Official gazette publication confirmation e-mailed
  5. Published for opposition
  6. Notification of notice of publication e-mailed
  7. Approved for pub - principal register
  8. Assigned to examiner
  9. New application office supplied data entered
  10. New application entered
FAQ

About CURE8

Who owns the trademark "CURE8"?

The USPTO trademark "CURE8" (application 97766262) is owned by Progenics Pharmaceuticals, Inc.

What is the status of "CURE8"?

Its status at the USPTO is: registered.

When was "CURE8" registered?

It was registered on January 16, 2024.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull CURE8 and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019d2b50-1f49-75c9-9864-5feb9ef2ab4d
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d2b50-1f49-75c9-9864-5feb9ef2ab4d",
  "object": "trademark",
  "mark_text": "CURE8",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "US",
  "application_number": "97766262",
  "filing_date": "2023-01-24",
  "nice_classes": [
    42
  ],
  "owners": [
    {
      "name": "Progenics Pharmaceuticals, Inc.",
      "entity_id": "ent_019f285f-865e-71ce-91bd-fb51977fd38d"
    }
  ]
}